https://medicalaffairs.travere.com/ 2026-06-30T15:33:46+00:00 https://medicalaffairs.travere.com/search-results/ 2025-10-30T15:04:42+00:00 https://medicalaffairs.travere.com/search-medical/ 2026-01-06T12:24:57+00:00 https://medicalaffairs.travere.com/contact/ 2026-02-25T08:40:14+00:00 https://medicalaffairs.travere.com/medical-information/ 2026-02-25T08:41:46+00:00 https://medicalaffairs.travere.com/find-your-msl/ 2026-02-25T08:42:12+00:00 https://medicalaffairs.travere.com/publications/ 2026-02-25T08:44:26+00:00 https://medicalaffairs.travere.com/about-us/ 2026-02-25T08:44:42+00:00 https://medicalaffairs.travere.com/igan/ 2026-05-14T12:41:05+00:00 https://medicalaffairs.travere.com/fsgs/ 2026-05-20T11:08:41+00:00 https://medicalaffairs.travere.com/fsgs/about-fsgs/ 2026-05-22T17:09:05+00:00 https://medicalaffairs.travere.com/fsgs/symptoms-and-diagnosis/ 2026-05-22T17:09:15+00:00 https://medicalaffairs.travere.com/fsgs/management/ 2026-05-22T17:09:26+00:00 https://medicalaffairs.travere.com/path-2-progress/ 2026-05-22T20:42:43+00:00 https://medicalaffairs.travere.com/igan/about-igan/ 2026-05-25T06:48:54+00:00 https://medicalaffairs.travere.com/igan/sparsentan-igan-clinical-trials/ 2026-05-25T06:49:18+00:00 https://medicalaffairs.travere.com/igan/management/ 2026-05-26T09:43:32+00:00 https://medicalaffairs.travere.com/igan/symptoms-and-diagnosis/ 2026-05-29T21:33:21+00:00 https://medicalaffairs.travere.com/meetings-events/ 2026-06-01T20:15:47+00:00 https://medicalaffairs.travere.com/fsgs/sparsentan-clinical-trials/ 2026-06-04T16:27:36+00:00 https://medicalaffairs.travere.com/podcasts/ 2026-08-21T18:35:27+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/ 2026-08-25T18:01:33+00:00 https://medicalaffairs.travere.com/meetings-events/simd-2024/ 2025-11-02T22:01:08+00:00 https://medicalaffairs.travere.com/meetings-events/glomcon-webinar-2025-sparsentan-igan/ 2026-01-07T19:50:58+00:00 https://medicalaffairs.travere.com/meetings-events/ssiem-annual-symposium-2024/ 2026-02-05T16:58:41+00:00 https://medicalaffairs.travere.com/meetings-events/glomcon-hawaii-2025/ 2026-02-20T12:43:34+00:00 https://medicalaffairs.travere.com/meetings-events/et-19-conference-2025/ 2026-02-20T12:44:07+00:00 https://medicalaffairs.travere.com/meetings-events/travere-isn-webinar-new-dawn-igan-sparsentan/ 2026-03-06T18:51:13+00:00 https://medicalaffairs.travere.com/meetings-events/nkf-2026/ 2026-07-06T15:01:41+00:00 https://medicalaffairs.travere.com/meetings-events/gmdi-2024/ 2026-07-08T16:06:13+00:00 https://medicalaffairs.travere.com/meetings-events/asn-kidney-week-2026/ 2026-09-02T18:24:36+00:00 https://medicalaffairs.travere.com/publications/humanistic-burden-igan-kidney-disease/ 2025-10-20T00:54:28+00:00 https://medicalaffairs.travere.com/publications/population-risk-predictors-make-fsgs-cure-ckd/ 2025-10-20T00:55:56+00:00 https://medicalaffairs.travere.com/publications/risk-factors-iga-nephropathy-cure-ckd-registry/ 2025-10-20T00:56:50+00:00 https://medicalaffairs.travere.com/publications/health-state-utility-iga-nephropathy/ 2025-10-20T00:59:20+00:00 https://medicalaffairs.travere.com/publications/fsgs-clinical-histopathology-adults/ 2025-10-20T01:31:03+00:00 https://medicalaffairs.travere.com/publications/clinicopathological-characteristics-of-adult-iga-nephropathy-in-the-united-states/ 2025-10-20T01:35:10+00:00 https://medicalaffairs.travere.com/publications/efficacy-safety-immunosuppressive-therapy-fsgs/ 2025-10-20T01:53:35+00:00 https://medicalaffairs.travere.com/publications/dual-antagonist-sparsentan-igan-fsgs-treatment/ 2025-10-20T01:59:11+00:00 https://medicalaffairs.travere.com/publications/long-term-outcomes-nephrotic-syndrome-biopsy-proteinuria/ 2025-10-29T21:22:34+00:00 https://medicalaffairs.travere.com/publications/fsgs-patient-carepartner-burden/ 2025-10-29T21:23:23+00:00 https://medicalaffairs.travere.com/publications/sparsentan-fsgs-glomerular-hemodynamics-mouse-model/ 2025-12-12T21:16:57+00:00 https://medicalaffairs.travere.com/publications/sparsentan-side-effects-male-fertility-toxicity/ 2025-12-12T21:18:47+00:00 https://medicalaffairs.travere.com/publications/efficacy-safety-raas-inhibitors-primary-fsgs-treatment/ 2025-12-12T22:12:55+00:00 https://medicalaffairs.travere.com/publications/phase-3-sparsentan-irbesartan-fsgs-duplex-study-design/ 2026-01-01T18:19:27+00:00 https://medicalaffairs.travere.com/publications/difference-primary-secondary-fsgs-urine-biomarkers/ 2026-01-08T15:08:53+00:00 https://medicalaffairs.travere.com/publications/sparsentan-phase-3-duplex-study-fsgs-baseline-characteristics/ 2026-01-08T15:54:04+00:00 https://medicalaffairs.travere.com/publications/international-physicians-delphi-survey-igan-patients/ 2026-01-09T04:08:58+00:00 https://medicalaffairs.travere.com/publications/quality-of-life-cystinuria-tiopronin-therapy/ 2026-01-13T17:41:03+00:00 https://medicalaffairs.travere.com/publications/protective-mechanism-sparsentan-chronic-kidney-disease-models/ 2026-01-15T07:26:48+00:00 https://medicalaffairs.travere.com/publications/kidney-failure-fsgs-usrds-cohort-study/ 2026-02-12T14:44:17+00:00 https://medicalaffairs.travere.com/publications/sparsentan-protect-trial-iga-nephropathy-baseline-characteristics/ 2026-02-12T19:18:18+00:00 https://medicalaffairs.travere.com/publications/iga-nephropathy-mortality-kidney-failure-cardiovascular-disease-real-world/ 2026-02-20T17:16:51+00:00 https://medicalaffairs.travere.com/publications/kidney-failure-iga-nephropathy-usrds-cohort-study/ 2026-02-20T22:07:35+00:00 https://medicalaffairs.travere.com/publications/sparsentan-iga-nephropathy-protect-interim-analysis/ 2026-02-20T23:23:04+00:00 https://medicalaffairs.travere.com/publications/iga-nephropathy-proteinuria-kidney-function-healthcare-costs/ 2026-02-20T23:38:49+00:00 https://medicalaffairs.travere.com/publications/pbpk-model-sparsentan-drug-interaction-potential/ 2026-02-23T20:13:37+00:00 https://medicalaffairs.travere.com/publications/humanistic-economic-burden-iga-nephropathy-literature-review/ 2026-02-25T22:41:27+00:00 https://medicalaffairs.travere.com/publications/proteinuria-remission-fsgs-sparsentan-duet-trial/ 2026-02-25T23:05:08+00:00 https://medicalaffairs.travere.com/publications/sparsentan-first-treatment-nonimmunosuppressive-proteinuria-reduction-iga-nephropathy/ 2026-03-10T15:49:17+00:00 https://medicalaffairs.travere.com/publications/dual-inhibition-ras-endothelin-1-ckd-treatment/ 2026-03-10T16:25:25+00:00 https://medicalaffairs.travere.com/publications/sparsentan-ameliorates-glomerular-hypercellularity-inflammation-iga-nephropathy/ 2026-03-10T17:33:38+00:00 https://medicalaffairs.travere.com/publications/duet-phase-2-sparsentan-fsgs-efficacy-safety/ 2026-03-11T16:29:34+00:00 https://medicalaffairs.travere.com/publications/sparsentan-losartan-iga-nephropathy-gddy-mouse-model/ 2026-03-16T13:07:43+00:00 https://medicalaffairs.travere.com/publications/sparsentan-versus-irbesartan-in-focal-segmental-glomerulosclerosis/ 2026-04-08T20:04:53+00:00 https://medicalaffairs.travere.com/publications/sparsentan-dapagliflozin-pharmacokinetics-drug-interaction-study/ 2026-04-15T14:38:38+00:00 https://medicalaffairs.travere.com/publications/protect-sparsentan-proteinuria-complete-remission/ 2026-05-08T16:06:43+00:00 https://medicalaffairs.travere.com/publications/targeting-et-1-and-ang-ii-in-glomerular-disease/ 2026-05-20T19:21:02+00:00 https://medicalaffairs.travere.com/publications/epidemiology-burden-fsgs-us-veterans/ 2026-05-20T20:27:04+00:00 https://medicalaffairs.travere.com/publications/sparsentan-duet-ole-fsgs-partial-remission/ 2026-05-20T20:29:42+00:00 https://medicalaffairs.travere.com/publications/sparsentan-clinical-trials-glomerular-diseases-endpoints-parasol/ 2026-05-22T19:49:20+00:00 https://medicalaffairs.travere.com/publications/protect-trial-kidney-health-initiative-endpoints-iga-nephropathy/ 2026-06-01T21:06:00+00:00 https://medicalaffairs.travere.com/publications/fsgs-prevalence-economic-burden-proteinuria/ 2026-06-03T14:05:45+00:00 https://medicalaffairs.travere.com/publications/urine-cystine-quantification-binding-thiol-drugs/ 2026-06-12T14:13:41+00:00 https://medicalaffairs.travere.com/publications/cardiovascular-kidney-failure-mortality-fsgs-real-world/ 2026-06-15T19:23:32+00:00 https://medicalaffairs.travere.com/publications/kdigo-2025-igan-guideline/ 2026-06-26T13:52:48+00:00 https://medicalaffairs.travere.com/publications/long-term-outcomes-in-iga-nephropathy/ 2026-06-27T00:25:10+00:00 https://medicalaffairs.travere.com/publications/practical-considerations-sparsentan-igan-clinical-practice/ 2026-06-30T22:19:19+00:00 https://medicalaffairs.travere.com/publications/review-clinical-humanistic-economic-burden-fsgs/ 2026-07-17T18:34:03+00:00 https://medicalaffairs.travere.com/publications/sparsentan-irbesartan-pediatric-fsgs-duplex-study/ 2026-08-24T19:30:29+00:00 https://medicalaffairs.travere.com/publications/protect-2-year-results-sparsentan-vs-irbesartan-iga-nephropathy/ 2026-09-15T20:02:24+00:00 https://medicalaffairs.travere.com/congress-materials/urinary-biomarker-analysis-reveals-rapid-intrarenal-anti-inflammatory-and-anti-fibrotic-effects-of-sparsentan-in-iga-nephropathy-in-the-spartan-study/ 2026-03-11T14:35:40+00:00 https://medicalaffairs.travere.com/congress-materials/spartan-igan-first-line-interim-analysis/ 2026-03-11T14:55:20+00:00 https://medicalaffairs.travere.com/congress-materials/sparsentan-sglt2i-iga-nephropathy-protect-ole/ 2026-03-11T15:01:23+00:00 https://medicalaffairs.travere.com/congress-materials/protectole-sparsentan-maximized-irbesartan-igan/ 2026-03-11T15:02:14+00:00 https://medicalaffairs.travere.com/congress-materials/sparsentan-sglt2i-combination-igan-case-series/ 2026-03-11T15:03:02+00:00 https://medicalaffairs.travere.com/congress-materials/protect-proteinuria-remission-egfr/ 2026-03-11T15:03:39+00:00 https://medicalaffairs.travere.com/congress-materials/protect-posthoc-kidney-biopsy/ 2026-03-11T15:26:34+00:00 https://medicalaffairs.travere.com/congress-materials/wcn-2026-poster-radar-transplant-igan-fsgs-mcd/ 2026-03-27T22:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/wcn-2026-visual-abstract-protect-time-from-biopsy/ 2026-03-27T22:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/wcn-2026-poster-protect-time-from-biopsy/ 2026-03-27T22:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/wcn-2026-poster-protect-mest-c-subgroups/ 2026-03-27T22:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/wcn-2026-poster-sparsentan-iga-nephropathy-gddy-mouse/ 2026-03-27T22:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/sparsentan-proteinuria-igan-case-series/ 2026-04-01T19:25:27+00:00 https://medicalaffairs.travere.com/congress-materials/anna-2026-visual-abstract-protect-time-from-biopsy/ 2026-04-25T23:06:18+00:00 https://medicalaffairs.travere.com/congress-materials/anna-2026-visual-abstract-duplex-low-proteinuria-thresholds/ 2026-04-25T23:09:00+00:00 https://medicalaffairs.travere.com/congress-materials/duplex-pediatric-fsgs/ 2026-05-01T21:15:13+00:00 https://medicalaffairs.travere.com/congress-materials/duplex-proteinuria-remission-fsgs/ 2026-05-01T21:15:52+00:00 https://medicalaffairs.travere.com/congress-materials/nkf-2026-poster-sparsentan-sglt2i-case-series-proteinuria/ 2026-05-07T12:12:38+00:00 https://medicalaffairs.travere.com/congress-materials/nkf-2026-poster-peer-program-rkd-implementation-science/ 2026-05-07T12:12:55+00:00 https://medicalaffairs.travere.com/congress-materials/protect-subgroup-analysis-proteinuria/ 2026-05-20T11:35:20+00:00 https://medicalaffairs.travere.com/congress-materials/era-2026-presentation-duplex-ole-sparsentan-proteinuria/ 2026-06-04T19:35:51+00:00 https://medicalaffairs.travere.com/congress-materials/atc-2026-poster-sparx-spartan-cohort-b/ 2026-06-21T18:45:00+00:00 https://medicalaffairs.travere.com/congress-materials/duplex-ole-sparsentan-antiproteinuric-effect/ 2026-07-06T14:58:35+00:00 https://medicalaffairs.travere.com/congress-materials/duplex-baseline-proteinuria-subgroups/ 2026-07-09T16:40:38+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-visual-abstract-protect-time-from-biopsy/ 2026-08-03T19:29:11+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-poster-protect-time-from-biopsy/ 2026-08-03T19:32:59+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-poster-spartan-biomarkers-baseline-proteinuria-posthoc/ 2026-08-05T18:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-poster-duplex-double-blind-baseline-proteinuria-posthoc/ 2026-08-05T18:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-visual-abstract-duplex-double-blind-baseline-proteinuria-posthoc/ 2026-08-05T18:30:00+00:00 https://medicalaffairs.travere.com/congress-materials/glomcon-2026-infographic-duplex-double-blind-baseline-proteinuria-posthoc/ 2026-08-05T18:30:00+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/unmet-needs-in-igan/ 2026-03-31T13:15:23+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/guideline-implementation-challenges/ 2026-04-09T13:30:07+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/igan-treatment-revolution/ 2026-04-09T13:35:21+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/igan-case-files/ 2026-04-22T19:16:47+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/igan-guideline-overview/ 2026-05-12T13:14:35+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/fsgs-introduction/ 2026-05-18T19:40:10+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/rethinking-igan-community-nephrologists/ 2026-05-19T21:40:05+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/endothelin-proteinuria-glomerular-pathophysiology/ 2026-05-21T22:12:08+00:00 https://medicalaffairs.travere.com/podcasts/nkf-milestones-igan-fsgs/ 2026-05-27T13:55:48+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/role-of-endothelin-in-igan/ 2026-06-01T17:59:52+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/ 2026-06-25T19:46:41+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/fsgs-podocytopathy/ 2026-06-29T22:02:47+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/ 2026-07-10T15:37:56+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/podocyte-problem-fsgs/ 2026-07-13T13:56:59+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/proteinuria-first-fsgs/ 2026-07-13T13:57:19+00:00 https://medicalaffairs.travere.com/podcasts/kdigo/treating-fsgs-steroids-deara/ 2026-07-13T13:57:37+00:00 https://medicalaffairs.travere.com/podcasts/rare-kidney-disease-show/fsgs-management-proteinuria-clinical-data/ 2026-08-21T15:25:19+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/igan-biomarkers-part-two/ 2025-12-16T18:14:49+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/igan-biomarkers-part-one/ 2025-12-16T18:16:37+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/informed-healthcare-for-patients-with-igan/ 2026-01-22T15:31:09+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/fsgs-clinical-trial-endpoints-proteinuria/ 2026-02-13T14:14:16+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/fsgs-disease-progression-and-humanistic-burden/ 2026-05-28T16:36:58+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/fsgs-a-new-era-in-treatment/ 2026-08-17T14:00:31+00:00 https://medicalaffairs.travere.com/rare-kidney-disease-news/advancing-care-in-pediatric-fsgs/ 2026-08-25T17:59:55+00:00